thyssenkrupp nucera

thyssenkrupp nucera is leasing a hall of more than 7,500 m² in Portugal and is building a central assembly centre for electrolyser cells there; construction is planned to start in winter 2026 and cell assembly is to begin in 2028. The investment is stated at €10–14 million, and the Portuguese government is supporting the project with around €3.7 million. Partially automated processes are intended to shift assembly from the customer to the manufacturer, with expected throughput and time advantages; the company has not yet given concrete capacity figures. The share reacted positively on the stock market and reached its highest level since June, technical indicators show strength, but accompanying volumes remained moderate. » More on finanzen.net

Thyssenkrupp nucera recorded incoming orders of €471m (+96%) in the first nine months, but suffered a sharp drop in revenue to €354m and an EBIT of -€69m. Drivers included large orders such as the 300-megawatt project from Moeve and market entry to India via a partnership with BHEL, while the green hydrogen segment saw revenue declines after completion of major reference projects. Management is discontinuing its series production for high-temperature electrolysis, causing one-off charges of around €30m in the fourth quarter and cutting the full-year EBIT guidance to -€105m to -€75m; the revenue forecast is now €450–500m. The strong chlor-alkali business and a net cash position of €627m are positive factors, but cash flow remains strained and further uncertainties persist. » More on finanzen.net

The share of thyssenkrupp nucera fell about 3.3% to 7.78 EUR after exiting the SOEC program and cutting its forecast. The exit will lead to one‑off charges to EBIT of roughly 30 million EUR, mainly due to impairments and capitalized development costs. In the third quarter revenue was 145 million EUR, above expectations, and order intake grew by 29%. Nevertheless, the company lowered its full‑year EBIT forecast to -155 million to -135 million EUR and reduced the revenue guidance for green hydrogen, which pushed the positive quarterly performance into the background. » More on de.investing.com

thyssenkrupp nucera has cut its EBIT forecast for 2025/26 to minus €105 to minus €75 million (previously minus €80 to minus €30 million), due to the exit from serial production of high‑temperature electrolysis (SOEC) and one‑off effects of €30 million in the fourth quarter. For the coming fiscal year a positive EBIT effect of €10 million and a positive cash flow of €20 million are expected. Revenue guidance was lowered to €450–500 million, and order intake is now expected at €550–670 million. The stock reacted negatively and fell in after‑hours trading; thyssenkrupp holds slightly more than half of the shares. » More on finanzen.net

thyssenkrupp nucera will publish numbers for the quarter ending 30.06.2026 on 12.08.2026. On average 2 analysts expect a loss of -0.020 EUR per share (prior year: -0.010 EUR) and 4 analysts expect revenue of 126.3 million EUR (prior year: 184.0 million), a decline of about 31.4%. For the current fiscal year 8 analysts forecast a loss per share of -0.346 EUR and revenue of 500.0 million EUR versus 845.2 million in the prior year. » More on finanzen.net